08:00 , Dec 10, 2015 |  BC Innovations  |  Product R&D

Spark in the brain

Spark Therapeutics Inc. is expanding beyond eye and blood diseases with its first foray into the brain for the rare neuronal disorder Batten disease, using a gene therapy delivered to the ependymal cells in the...
07:00 , Jul 20, 2015 |  BC Week In Review  |  Company News

Abeona Therapeutics, University of Nebraska deal

The UNeMed Corp. tech transfer arm of the university’s medical center granted Abeona exclusive, worldwide rights to develop and commercialize ABO-201 to treat juvenile Batten disease. The parties declined to provide financial details. ABO-201,...